Scandinavian Pharmaceuticals ApS: Financial statements 2025
CVR: 41233788
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Scandinavian Pharmaceuticals ApS (CVR 41233788) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 40,000. The solvency ratio was 100%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 40,000
- Total Assets
- DKK 40,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 0 | 0 | 40K | - |
| 2024 | - | 0 | 0 | 40K | - |
| 2023 | - | - | 0 | 40K | - |
| 2022 | - | - | -5K | 0 | - |
| 2021 | - | - | -2K | 40K | - |
Official annual report
How creditworthy is Scandinavian Pharmaceuticals ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Scandinavian Pharmaceuticals ApS has published its annual report for 2024. Gross profit came to DKK 0, and the net result was DKK 0.
About Scandinavian Pharmaceuticals ApS
Scandinavian Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in Viby J, founded in 2020. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The management consists of Ali Jasim Mohammad Jamil. The company is owned by Ali Jasim Mohammad Jamil. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 40,000.